• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维化疾病中的线粒体自噬:分子机制与治疗应用

Mitophagy in fibrotic diseases: molecular mechanisms and therapeutic applications.

作者信息

Cui Xinyan, Zhou Zekun, Tu Hua, Wu Jianjun, Zhou Jian, Yi Qiao, Liu Ousheng, Dai Xiaohan

机构信息

Hunan Key Laboratory of Oral Health Research, Hunan Clinical Research Center of Oral Major Diseases, Oral Health and Academician Workstation for Oral-maxilofacial, Regenerative Medicine and Xiangya Stomatological Hospital, Xiangya School of Stomatology, Central South University, Changsha, Hunan, China.

Salivary Gland Disease Center and Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, Beijing Laboratory of Oral Health and Beijing Stomatological Hospital, Capital Medical University, Beijing, China.

出版信息

Front Physiol. 2024 Aug 9;15:1430230. doi: 10.3389/fphys.2024.1430230. eCollection 2024.

DOI:10.3389/fphys.2024.1430230
PMID:39183973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11341310/
Abstract

Mitophagy is a highly precise process of selective autophagy, primarily aimed at eliminating excess or damaged mitochondria to maintain the stability of both mitochondrial and cellular homeostasis. In recent years, with in-depth research into the association between mitophagy and fibrotic diseases, it has been discovered that this process may interact with crucial cellular biological processes such as oxidative stress, inflammatory responses, cellular dynamics regulation, and energy metabolism, thereby influencing the occurrence and progression of fibrotic diseases. Consequently, modulating mitophagy holds promise as a therapeutic approach for fibrosis. Currently, various methods have been identified to regulate mitophagy to prevent fibrosis, categorized into three types: natural drug therapy, biological therapy, and physical therapy. This review comprehensively summarizes the current understanding of the mechanisms of mitophagy, delves into its biological roles in fibrotic diseases, and introduces mitophagy modulators effective in fibrosis, aiming to provide new targets and theoretical basis for the investigation of fibrosis-related mechanisms and disease prevention.

摘要

线粒体自噬是一种高度精确的选择性自噬过程,主要旨在清除多余或受损的线粒体,以维持线粒体和细胞内稳态的稳定性。近年来,随着对线粒体自噬与纤维化疾病之间关联的深入研究,发现该过程可能与氧化应激、炎症反应、细胞动力学调节和能量代谢等关键细胞生物学过程相互作用,从而影响纤维化疾病的发生和发展。因此,调节线粒体自噬有望成为治疗纤维化的一种方法。目前,已确定多种调节线粒体自噬以预防纤维化的方法,分为三类:天然药物治疗、生物治疗和物理治疗。本综述全面总结了目前对线粒体自噬机制的认识,深入探讨了其在纤维化疾病中的生物学作用,并介绍了对纤维化有效的线粒体自噬调节剂,旨在为纤维化相关机制的研究和疾病预防提供新的靶点和理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4208/11341310/bfe93a0a9f52/fphys-15-1430230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4208/11341310/ff4b9399bef8/fphys-15-1430230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4208/11341310/bfe93a0a9f52/fphys-15-1430230-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4208/11341310/ff4b9399bef8/fphys-15-1430230-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4208/11341310/bfe93a0a9f52/fphys-15-1430230-g002.jpg

相似文献

1
Mitophagy in fibrotic diseases: molecular mechanisms and therapeutic applications.纤维化疾病中的线粒体自噬:分子机制与治疗应用
Front Physiol. 2024 Aug 9;15:1430230. doi: 10.3389/fphys.2024.1430230. eCollection 2024.
2
Mediators of mitophagy that regulate mitochondrial quality control play crucial role in diverse pathophysiology.调控线粒体质量控制的自噬介体在多种病理生理学中起着关键作用。
Cell Biol Toxicol. 2021 Jun;37(3):333-366. doi: 10.1007/s10565-020-09561-1. Epub 2020 Oct 17.
3
Mitochondrial Dysfunction as a Pathogenic Mediator of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.线粒体功能障碍作为慢性阻塞性肺疾病和特发性肺纤维化的致病介质。
Ann Am Thorac Soc. 2018 Dec;15(Suppl 4):S266-S272. doi: 10.1513/AnnalsATS.201808-585MG.
4
The role of autophagy and mitophagy in cancers.自噬和线粒体自噬在癌症中的作用。
Arch Physiol Biochem. 2022 Apr;128(2):281-289. doi: 10.1080/13813455.2019.1675714. Epub 2019 Oct 9.
5
The Role of Mitochondrial Dynamics and Mitophagy in Carcinogenesis, Metastasis and Therapy.线粒体动力学和线粒体自噬在癌症发生、转移及治疗中的作用
Front Cell Dev Biol. 2020 Jun 10;8:413. doi: 10.3389/fcell.2020.00413. eCollection 2020.
6
Emerging Role of Mitophagy in Inflammatory Diseases: Cellular and Molecular Episodes.自噬在炎症性疾病中的新作用:细胞和分子事件。
Curr Pharm Des. 2020;26(4):485-491. doi: 10.2174/1381612826666200107144810.
7
Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?线粒体功能障碍与线粒体自噬:糖尿病肾病的起始与终结?
Br J Pharmacol. 2014 Apr;171(8):1917-42. doi: 10.1111/bph.12503.
8
Pirfenidone inhibits myofibroblast differentiation and lung fibrosis development during insufficient mitophagy.吡非尼酮可抑制自噬不足时肌成纤维细胞分化和肺纤维化的发展。
Respir Res. 2017 Jun 2;18(1):114. doi: 10.1186/s12931-017-0600-3.
9
The role of mitophagy in the development of chronic kidney disease.自噬在慢性肾脏病发展中的作用。
PeerJ. 2024 Apr 25;12:e17260. doi: 10.7717/peerj.17260. eCollection 2024.
10
Leukemia and mitophagy: a novel perspective for understanding oncogenesis and resistance.白血病与线粒体自噬:一种理解肿瘤发生和耐药性的新视角。
Ann Hematol. 2024 Jul;103(7):2185-2196. doi: 10.1007/s00277-024-05635-w. Epub 2024 Jan 29.

引用本文的文献

1
Redox Imbalance in Cystic Fibrosis: The Multifaceted Role of Oxidative Stress.囊性纤维化中的氧化还原失衡:氧化应激的多方面作用
Pharmaceuticals (Basel). 2025 May 24;18(6):784. doi: 10.3390/ph18060784.
2
Mitochondrial Dysfunction: The Silent Catalyst of Kidney Disease Progression.线粒体功能障碍:肾病进展的隐匿催化剂
Cells. 2025 May 28;14(11):794. doi: 10.3390/cells14110794.

本文引用的文献

1
ACSS3 regulates the metabolic homeostasis of epithelial cells and alleviates pulmonary fibrosis.ACSS3 调节上皮细胞的代谢稳态并减轻肺纤维化。
Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166960. doi: 10.1016/j.bbadis.2023.166960. Epub 2023 Nov 17.
2
Cardiomyocyte-specific deletion of endothelin receptor A (ET) obliterates cardiac aging through regulation of mitophagy and ferroptosis.心肌细胞特异性内皮素受体 A (ET) 缺失通过调节线粒体自噬和铁死亡来消除心脏衰老。
Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166958. doi: 10.1016/j.bbadis.2023.166958. Epub 2023 Nov 12.
3
Activation of moderate autophagy promotes survival of fat graft.
适度自噬的激活促进脂肪移植的存活。
FASEB J. 2023 Dec;37(12):e23289. doi: 10.1096/fj.202300892R.
4
Non-steroidal mineralocorticoid receptor antagonist finerenone ameliorates mitochondrial dysfunction via PI3K/Akt/eNOS signaling pathway in diabetic tubulopathy.非甾体类盐皮质激素受体拮抗剂非奈利酮通过 PI3K/Akt/eNOS 信号通路改善糖尿病肾小管病变中的线粒体功能障碍。
Redox Biol. 2023 Dec;68:102946. doi: 10.1016/j.redox.2023.102946. Epub 2023 Oct 24.
5
MANF stimulates autophagy and restores mitochondrial homeostasis to treat autosomal dominant tubulointerstitial kidney disease in mice.MANF 通过刺激自噬作用并恢复线粒体动态平衡来治疗小鼠常染色体显性遗传性肾小管间质性肾病。
Nat Commun. 2023 Oct 14;14(1):6493. doi: 10.1038/s41467-023-42154-0.
6
Poricoic acid A induces mitophagy to ameliorate podocyte injury in diabetic kidney disease via downregulating FUNDC1.猪苓酸A通过下调FUNDC1诱导线粒体自噬以改善糖尿病肾病中的足细胞损伤。
J Biochem Mol Toxicol. 2023 Dec;37(12):e23503. doi: 10.1002/jbt.23503. Epub 2023 Sep 14.
7
Insights of mitochondrial involvement in alcoholic fatty liver disease.线粒体在酒精性脂肪性肝病中的作用见解
J Cell Physiol. 2023 Oct;238(10):2175-2190. doi: 10.1002/jcp.31100. Epub 2023 Aug 29.
8
PPARδ activation improves cardiac mitochondrial homeostasis in desmin deficient mice but does not alleviate systolic dysfunction.过氧化物酶体增殖物激活受体δ(PPARδ)的激活可改善结蛋白缺陷小鼠的心脏线粒体稳态,但不能缓解收缩功能障碍。
J Mol Cell Cardiol. 2023 Oct;183:27-41. doi: 10.1016/j.yjmcc.2023.08.005. Epub 2023 Aug 19.
9
Resmetirom: An Orally Administered, Smallmolecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis.瑞美替隆:一种口服的小分子、肝脏靶向、β 选择性甲状腺激素受体激动剂,用于治疗非酒精性脂肪性肝病和非酒精性脂肪性肝炎。
touchREV Endocrinol. 2023 May;19(1):60-70. doi: 10.17925/EE.2023.19.1.60. Epub 2023 May 1.
10
Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish.运动干预可改善非酒精性脂肪肝病斑马鱼的线粒体质量。
Front Endocrinol (Lausanne). 2023 May 22;14:1162485. doi: 10.3389/fendo.2023.1162485. eCollection 2023.